See the factory by live video walkthrough
Book an on-site factory visit in GuangzhouStarting July 2024, the U.S. Modernization of Cosmetics Regulation Act (MoCRA) requires every lip care brand selling into the U.S. market to ensure its manufacturing facility is registered and each product is properly listed…
Starting July 2024, the U.S. Modernization of Cosmetics Regulation Act (MoCRA) requires every lip care brand selling into the U.S. market to ensure its manufacturing facility is registered and each product is properly listed with the FDA. This guide explains how sourcing managers and brand owners can meet MoCRA’s new compliance standards while maintaining launch timelines and supplier accountability.
Lip care products often fall under “ingestible exposure” risks because they are applied on the lips, increasing FDA interest in ingredient traceability and microbial safety. Buyers sourcing from overseas factories must request verifiable compliance documents early—ideally before packaging lock—to avoid shipment delays or market recall risks.
| Document / Test | Purpose | Owner |
|---|---|---|
| FDA Facility Registration Confirmation | Verifies plant authorization to produce for U.S. market | Manufacturer |
| Product Listing Data Sheet | Contains label name, formula, batch code | Responsible Person / Buyer |
| Ingredient Safety & Toxicology Report | Supports MoCRA requirement for safety substantiation | Manufacturer / Third-party lab |
| Microbiological & Stability Testing Results | Proves stability and microbial control for lip-contact formulations | Manufacturer |
| Label Artwork & Claims Review Record | Confirms labeling in compliance with FDA guidelines | Buyer |
A structured timeline helps avoid missed registration windows and supply disruptions:
Tip: Align pilot production before listing submission; only finished formulations with confirmed packaging should be listed to minimize update cycles.
Confirm FDA facility registration certificate Verify U.S. agent assignment letter Provide full INCI and formula disclosure Attach COA and SDS for each raw material Submit microbial and stability reports (≥90 days data) Check primary packaging material compatibility Review label text and ingredient panel compliance Approve label artwork before production Validate batch record retention process Share previous audit reports and certifications (ISO22716 / GMPC) Confirm MoCRA product listing submission acknowledgment Store safety substantiation file copy for internal audit Update post-market surveillance plan annually Prepare adverse event tracking SOP Ensure traceable batch number system for each lip SKU
Yes. Every U.S. or foreign cosmetic manufacturing facility producing lip care items for U.S. retail must register its site and product categories with the FDA.
No. Each product (shade or variant with unique name/label) requires a separate product listing entry.
You must require the supplier to complete facility registration before product shipment. Buyers can check registration via the FDA Cosmetic Facility portal once public listings are available.
Yes. Any material change in formulation, labeling, or intended use requires an updated listing submission.
Products making sun protection claims fall under OTC drug rules and must follow both MoCRA cosmetic requirements and FDA OTC drug monograph filings.
Start your compliance readiness now by gathering registration details from each partner factory and preparing labeling for FDA submission. LAEYO Labs offers facility-level documentation and compliant formulation support tailored for U.S. MoCRA updates.